Protalix BioTherapeutics
PLX
#8903
Rank
NZ$0.24 B
Marketcap
NZ$3.01
Share price
0.58%
Change (1 day)
-0.15%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2025 (TTM): NZ$15.3 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are NZ$61.94 Million. In 2024 the company made an earning of NZ$9.02 Million a decrease over its 2023 earnings that were of NZ$20.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$15.3 M69.68%
2024 NZ$9.02 M-55.62%
2023 NZ$20.33 M-199.05%
2022 -NZ$20.53 Million-40.38%
2021 -NZ$34.44 Million-732.31%
2020 NZ$5.44 M-130.53%
2019 -NZ$17.84 Million189.85%
2018 -NZ$6.16 Million-95.29%
2017 -NZ$0.14 Billion308.12%
2016 -NZ$32.03 Million-32.37%
2015 -NZ$47.35 Million10.11%
2014 -NZ$43 Million-7.59%
2013 -NZ$46.53 Million
2011 -NZ$53.89 Million-19.39%
2010 -NZ$66.85 Million20.87%
2009 -NZ$55.3 Million32.26%
2008 -NZ$41.82 Million-5.46%
2007 -NZ$44.23 Million
2004 -NZ$0.29 Million12.35%
2003 -NZ$0.26 Million-11.1%
2002 -NZ$0.29 Million-57.03%
2001 -NZ$0.67 Million1.03%
2000 -NZ$0.67 Million-53.22%
1999 -NZ$1.42 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amicus Therapeutics
FOLD
NZ$8.61 M-45.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$1.00 B 6,251.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.50 B 128,978.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.06 B 19,198.63%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel